Macro Dragon: WK # 44 - The Trillionaire Week  =  MAGA [Microsoft, Apple, Google, Amazon]

Macro Dragon: WK # 44 - The Trillionaire Week = MAGA [Microsoft, Apple, Google, Amazon]

Macro 2 minutes to read
Kay Van-Petersen

Global Macro Strategist

Summary:  Macro Dragon = Cross-Asset Daily Views that could cover anything from tactical positioning, to long-term thematic investments, key events & inflection points in the markets, all with the objective of consistent wealth creation overtime.


(These are solely the views & opinions of KVP, & do not constitute any trade or investment recommendations. By the time you synthesize this, things may have changed.)

Macro Dragon: WK # 44, The Trillionaire Week = MAGA [Microsoft, Apple, Google, Amazon]

 

Top of Mind…

  • Happy Monday Folks & Welcome to WK # 44

  • Hope everyone had a diversified, rewarding, restful & growth filled wkd

  • What kind of wk are you trying to have up ahead, as it’s the wk before the Nov 3 elections?

  • Focus: Likely four key parts, with really only the first two getting the lion’s share of focus & attention.

  • One: We are still wondering whether this soap opera on a US stimulus will pan out – timing gets even stranger given countdown – as despite Pelosi’s 48hr timeline having long expired on Weds last wk, there still seems to be a corridor for discussion. How much is window dressing versus real intent from all parties – hard to know, however KVP will tell you one thing that is smart about this. It does make Mitch McConnell – who is up for re-election vs. a Amy McGrath a democratic ex-marine & mother – look even worse than usual.

  • Two: WK 44 is a Trillionaire wk, as we will get results MAGA – Microsoft, Apple, Google & Amazon, all whom have market caps over one trillion & it Apple’s case it rounds off to $2 Trillion. That’s just an insane number, that’s c. 10% of the US economy, c. 60% the value of Germany’s economy, c. +5x the GDP of Singapore or close to 1.5x the GDP of Australia. These four plus other earnings are going to be watched this wk – again, same theme of bounce in 3Q underlying econ. data should be supportive & focus likely on outlook.

  • Three: Brexit – discussions still ongoing with some choppiness being seen in sterling crosses. Once again the Dragon’s view is the structural skew is to the upside, with the downside not only capped, yet likely in such a scenario short-lived… yet overall this remains contrarian & off people’s radars. I.e. +4.5yrs, US election & WFH C19 lifestyle taking all the oxygen out of the investing/trading room.

  • Four: US election, we finally got a debate – yay! Not much to say here that has not already been captured. With a touch over a wk to go for D-day & given the pivotal 2020 year, hard to see anything truly game changing coming through. KVP will look to put out a short piece on a potential Trump upset – as once again he is the clear underdog – & what would be some potential cross-asset trades from an event-driven knee jerk reaction.

  • Earnings: In addition to MAGA, there are a number of large pharma & biotech names reporting this wk in the US. As well as the major banks & insurance names in Hong Kong.

  • Mon: SAP

  • Tue: Ping An (2318), Microsoft (MSFT), Novartis (NOVN), Pfizer (PFE), Merck & Co (MRK), Eli Lilly & Co (LLY)

  • Wed: China Life (2628), UPS, Visa (V), Mastercard (MA), Amgen (AMGN)

  • Thu: CCB (939), Sanofi (SAN), NTT Docomo (9437), Apple (AAPL), Amazon (AMZN), Alphabet/Google (GOOGL), Zuckbook (FB), Comcast (CMCSA), Shopify (SHOP)

  • Fri: Novo Nordisk (NOVOB), ABC (1288), BoC (3988), AbbVue (ABBV), Exxon (XOM), Chevron (CVX), Honeywell (HON)

  • Economics: Whilst durable goods, personal income & personal spending are always key in regards to US data, the focus here this wk will be on the first reading of 3Q GDP expected at c. +32% vs. a c. -31% in 2Q [and no, that does not take us back to where we were, need at least +46%, yet all the growth we are getting now is likely to be K-Shaped, i.e. the distribution is very different from a pre-covid world].

  • The Euro-Zone will also see flash regional 3Q GDPs, as well as for the block as a whole. China should have its PMIs coming through on Sat Oct 31, which could dictate the Start of Asia’s sentiment, Monday Morning in WK #45. Remember China is the clear outperformer growth wise globally, something we highlighted would be a theme for 2020 in our 2Q Outlook.

  • Central Banks: Canada 0.25%e/p, Brazil 2.00%e/p, ECB -0.50%e/p, BoJ -0.10%e/p

    Turkey Central Bank Inflation Report Wed 28 Oct @ 15:30 SGT

  • Fed Speak: Kaplan Thu 29 Oct @ 06:00 SGT – this is an odd one as technically they should be in black out, remember the Fed meet two days after the US election, next Thu Nov 5. Interestingly enough, looks like Kaplan is moderating a panel with the George Clooney of Central Banking, the man who has run the BoC & the BoE, Mark Carney.

  • Holidays: NZ & HK bank holidays today – its worth noting JP should be out on Nov 3.

  • Other: Note daylights savings shift across Europe.

-

Start-to-End = Gratitude + Integrity + Vision + Tenacity. Process > Outcome. Sizing > Idea.

This is the way 

KVP

Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.